Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort
NCT01565512Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- Nov 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Columbia University. Primary endpoint: Prevalence of pain/discomfort. Planned start Nov 2011; status: withdrawn.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01565512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565512.